Pharmacokinetics of a benzodithiin (RD3-0028) following aerosol treatment in rat

References

• ADJEI, A. and GARREN, J., 1990, Pulmonary delivery of peptide drugs: Effect of particle size on bioavailability of leuprolide acetate in healthy male volunteers. Pharmaceutical Research, 7, 565–569.
   PubMed Web of Science ®Google Scholar
• BORGSTROM, L. and NILSSON, M., 1990, A method for determination of the absolute pulmonary bioavailability of inhaled drugs: Terbutaline. Pharmaceutical Research, 7, 1068–1070.
   PubMed Web of Science ®Google Scholar
• GILBERT, B. E. and WYDE, P. R., 1988, Pharmacokinetics of ribavirin aerosol in mice. Antimicrobial Agents and Chemotherapy, 32, 117–121.
   PubMedGoogle Scholar
• GILBERT, B. E., WYDE, P. R., WILSON, S. Z. and ROBINS, R. K., 1991, Aerosol and intraperitoneal administration of ribavirin and ribavirin triacetate: Pharmacokinetics and protection of mice against intracerebral infection with influenza A/WSN virus. Antimicrobial Agents and Chemotherapy, 35, 1448–1453.
   PubMed Web of Science ®Google Scholar
• GROOTHUIS, J. R., GUTIERREZ, K. M. and LAUER, B. A., 1988, Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics, 82, 199–203.
   PubMed Web of Science ®Google Scholar
• GROOTHUIS, J. R., LEVIN, M. J., RODRIGUEZ, W., HALL, C. B., LONG, C. E., KIM, H. W., LAUER, B. A. and HEMMING, V. G., 1991, Use of intravenous gamma globulin to passively immunize high-risk children against respiratory syncytial virus: safety and pharmacokinetics. The RSVIG Study Group. Antimicrobial Agents and Chemotherapy, 35, 1469–1473.
   PubMedGoogle Scholar
• HALL, C. B., MCBRIDE, J. T., GALA, C. T., HILDRETH, S. W. and SCHNABEL, K. C., 1985, Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. Journal of the American Medical Association, 254, 3047–3051.
   PubMed Web of Science ®Google Scholar
• HENDERSON, F. W., COLLIER, A. M., CLYDE, W. A., JR and DENNY, F. W., 1979, Respiratory syncytial virus infections, reinfections and immunity: a prospective longitudinal study in young children. New England Journal of Medicine, 300, 530–534.
   PubMed Web of Science ®Google Scholar
• HRUSKA, J. F., MORROW, P. E., SUFFIN, S. C. and DOUGLAS, R. G., JR, 1982, In vivo inhibition of respiratory syncytial virus by ribavirin. Antimicrobial Agents and Chemotherapy, 21, 125–130.
   PubMed Web of Science ®Google Scholar
• JONES, K. M., LIAO, E., HOHNEKER, K., TURPIN, S. M., HENRY, M., SELINGER, K., HSYU, P. H., BOUCHER, R. C., KNOWLES, M. R and DUKES, G. E, 1997, Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosis. Pharmacotherapy, 17, 263–270.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI, S., YosinbA, T., MATSUMURA, R. and KOHEI, H., 1985, Disposition of 3H-fenoterol after inhalation in rats. Drug Research, 35, 360–363.
   Google Scholar
• KOMADA, F., IWAKAWA, S., YAMAMOTO, N., SAKAKIBARA, H. and OKUMURA, K., 1994, Intratracheal delivery of peptide and protein agents: absorption from solution and dry powder by rat lung. Journal of Pharmaceutical Sciences, 83, 863–867.
   PubMed Web of Science ®Google Scholar
• MACDONALD, N. E., HALL, C. B., SUFFIN, S. C., ALEXSON, C., HARRIS, P. J. and MANNING, J. A., 1982, Respiratory syncytial viral infection in infants with congenital heart disease. New England Journal of Medicine, 307, 397–400.
   PubMed Web of Science ®Google Scholar
• OHMIT, S. E., MOLER, F. W., MONTO, A. S. and KHAN, A. S., 1996, Ribavirin utilization and clinical effectiveness in children hospitalized with respiratory syncytial virus infection. Journal of Clinical Epidemiology, 49, 963–967.
   PubMed Web of Science ®Google Scholar
• OKUMURA, K., IWAKAWA, S., YOSHIDA, T., SEKI, T. and KOMADA, F., 1992, Intracheal delivery of insulin absorption from solution and aerosol by rat lung. International Journal of Pharmaceutics, 88, 63–73.
   Web of Science ®Google Scholar
• PRINCE, G. A., HEMMING, V. G., HORSWOOD, R. L., BARON, P. A., MURPHY, B. R. and CHANOCK, R. M., 1990, Mechanism of antibody-mediated viral clearance in irnmunotherapy of respiratory syncytial virus infection of cotton rats. Journal of Virology, 64, 3091–3092.
   PubMedGoogle Scholar
• SCHANKER, L. S. and HEMBERGER, J. A., 1983, Relation between molecular weight and pulmonary absorption rate of lipid-insoluble compounds in neonatal and adult rats. Biochemical Pharmacology, 32, 2599–2601.
   PubMed Web of Science ®Google Scholar
• SHIGETA, S., MORI, S., WATANABE, J., SOEDA, S., TAKAHASHI, K. and YAMASE, T., 1997, Synergistic anti-influenza virus A (Hi Ni) activities of PM-523 (polyoxometalate) and ribavirin in vitro and in vivo. Antimicrobial Agents and Chemotherapy, 41, 1423–1427.
   PubMedGoogle Scholar
• SHUTO, S., OBARA, T., TORIYA, M., HOSOYA, M., SNOECK, R., ANDREI, G., BALZARINI, J. and DE CLERCQ, E., 1992, New neplanocin analogues. 1. Synthesis of 6'-modified neplanocin A derivatives as broad-spectrum antiviral agents. Journal of Medicinal Chemistry, 35, 324–331.
   PubMed Web of Science ®Google Scholar
• SLY, P. and LE SOUEF, P., 1991, Inhaled therapy in paediatrics. Journal of Paediatrics and Child Health, 27, 7–10.
   PubMedGoogle Scholar
• SUDO, K., WATANABE, W., KONNO, K., SATO, R., KAJIYASHIKI, T., SHIGETA, S. and YOKOTA., T., 1999, Efficacy of RD3-0028 aerosol treatment against respiratory syncytial virus infection in irnmunosuppressed mice. Antimicrobial Agents and Chemotherapy, 43, 752–757.
   Google Scholar
• TAYLOR, G., 1990, The absorption and metabolism of xenobiotics in the lung. Advanced Drug Delivery Reviews, 5, 37–61.
   Google Scholar
• WATANABE, W., SUDO, K., SATO, R., KAJIYASHIKI, T., KONNO, K., SHIGETA, S. and YOKOTA, T., 1998, Novel anti-respiratory syncytial (RS) viral compounds: Benzodithiin derivatives. Biochemical and Biophysical Research Communications, 249, 922–926.
   PubMed Web of Science ®Google Scholar
• WYDE, P. R., WILSON, S. Z., GILBERT, B. E. and SMITH, R. H. A., 1986, Protection of mice from lethal influenza virus infection with high dose-short duration ribavirin aerosol. Antimicrobial Agents and Chemotherapy, 30, 942–944.
   PubMedGoogle Scholar